Adage Capital Partners
ALXN

Adage Capital Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-5,238,014
Closed -$962M 1131
2021
Q2
$962M Buy
5,238,014
+995,635
+23% +$183M 1.88% 4
2021
Q1
$649M Buy
4,242,379
+1,325,400
+45% +$203M 1.32% 8
2020
Q4
$456M Buy
2,916,979
+2,106,921
+260% +$329M 0.99% 11
2020
Q3
$92.7M Sell
810,058
-158,000
-16% -$18.1M 0.23% 93
2020
Q2
$109M Sell
968,058
-86,452
-8% -$9.7M 0.28% 79
2020
Q1
$94.7M Buy
1,054,510
+245,400
+30% +$22M 0.28% 85
2019
Q4
$87.5M Buy
809,110
+242,148
+43% +$26.2M 0.21% 125
2019
Q3
$55.5M Sell
566,962
-52,500
-8% -$5.14M 0.14% 188
2019
Q2
$81.1M Buy
619,462
+130,900
+27% +$17.1M 0.2% 129
2019
Q1
$66M Buy
488,562
+349,500
+251% +$47.2M 0.17% 155
2018
Q4
$13.5M Sell
139,062
-55,130
-28% -$5.37M 0.04% 433
2018
Q3
$27M Buy
194,192
+173,698
+848% +$24.1M 0.06% 338
2018
Q2
$2.54M Buy
20,494
+10,596
+107% +$1.32M 0.01% 686
2018
Q1
$1.1M Buy
+9,898
New +$1.1M ﹤0.01% 686
2017
Q4
Sell
-385,698
Closed -$54.1M 770
2017
Q3
$54.1M Buy
385,698
+35,817
+10% +$5.02M 0.13% 211
2017
Q2
$42.6M Buy
349,881
+118,479
+51% +$14.4M 0.1% 261
2017
Q1
$28.1M Sell
231,402
-33,600
-13% -$4.07M 0.07% 334
2016
Q4
$32.4M Buy
265,002
+104,593
+65% +$12.8M 0.09% 283
2016
Q3
$19.7M Buy
160,409
+129,065
+412% +$15.8M 0.05% 388
2016
Q2
$3.66M Sell
31,344
-37,219
-54% -$4.35M 0.01% 614
2016
Q1
$9.55M Sell
68,563
-237,000
-78% -$33M 0.03% 530
2015
Q4
$58.3M Buy
305,563
+25,500
+9% +$4.86M 0.15% 178
2015
Q3
$43.8M Sell
280,063
-14,100
-5% -$2.21M 0.12% 219
2015
Q2
$53.2M Sell
294,163
-17,000
-5% -$3.07M 0.13% 213
2015
Q1
$53.9M Sell
311,163
-83,037
-21% -$14.4M 0.13% 211
2014
Q4
$72.9M Buy
394,200
+74,700
+23% +$13.8M 0.18% 154
2014
Q3
$53M Sell
319,500
-44,400
-12% -$7.36M 0.13% 203
2014
Q2
$56.9M Buy
363,900
+15,200
+4% +$2.37M 0.15% 189
2014
Q1
$53M Sell
348,700
-160,100
-31% -$24.4M 0.14% 192
2013
Q4
$67.6M Sell
508,800
-83,700
-14% -$11.1M 0.18% 164
2013
Q3
$68.8M Sell
592,500
-200,000
-25% -$23.2M 0.2% 147
2013
Q2
$73.1M Buy
+792,500
New +$73.1M 0.23% 128